The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 1-7B Malignant Lymphoma: Clinical Trials and Observation Studies

Fri. Oct 11, 2019 10:10 AM - 11:10 AM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Shigeki Ito (Department of Medical Oncology, Iwate Medical University)

Dai Maruyama1, Ken Ohmachi2, Gakuto Ogawa3, Tomohiro Kinoshita4, Kensei Tobinai1, Tomonori Mizutani3, Nobuhiko Yamauchi5, Noriko Fukuhara6, Toshiki Uchida7, Kazuhito Yamamoto4, Kana Miyazaki8, Norifumi Tsukamoto9, Shinsuke Iida10, Takahiko Utsumi11, Isao Yoshida12, Yoshitaka Imaizumi13, Takashi Tokunaga14, Shinichiro Yoshida15, Yasufumi Masaki16, Tohru Murayama17, Yoshihiro Yakushijin18, Yoko Suehiro19, Kisato Nosaka20, Nobuaki Dobashi21, Junya Kuroda22, Yasushi Takamatsu23, Kiyoshi Ando2, Kenichi Ishizawa6, Michinori Ogura7, Tadashi Yoshino24, Tomomitsu Hotta25, Kunihiro Tsukasaki5, Hirokazu Nagai14 (1.Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Hematology Oncology, Tokai University School of Medicine, Isehara, Japan, 3.JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, 4.Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan, 5.Hematology, National Cancer Center Hospital East, Kashiwa, Japan, 6.Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan, 7.Hematology Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan, 8.Hematology Oncology, Mie University Graduate School of Medicine, Tsu, Japan, 9.Medicine and Clinical Science, Gunma University Hospital, Gunma, Japan, 10.Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan, 11.Hematology, Shiga General Hospital, Moriyama, Japan, 12.Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, 13.Haematology, Nagasaki University Hospital, Nagasaki, Japan, 14.Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 15.Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan, 16.Hematology and Immunology, Medicine, Kanazawa Medical University, Kahoku, Japan, 17.Hematology, Hyogo Cancer Center, Akashi, Japan, 18.First Department of Internal Medicine, Ehime University Hospital, Toon, Japan, 19.Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 20.Hematology, Kumamoto University Hospital, Kumamoto, Japan, 21.Clinical Oncology Hematology, The Jikei University Daisan Hospital, Komae, Japan, 22.Hematology Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 23.Medical Oncology, Hematology and Infectious Diseases, Fukuoka University, Fukuoka, Japan, 24.Pathology, Okayama University Graduate School of Medicine, Okayama, Japan, 25.National Cancer Center Hospital, Tokyo, Japan)

Ilseung Choi1, Yasuhiko Miyata2, Isao Yoshida3, Yoko Suehiro1, Yukio Hirabayashi4, Michihiro Hidaka5, Takuya Komeno6, Terutoshi Hishita7, Hironori Ueno8, Kazutaka Sunami9, Yuko Ogata10, Hiromi Iwasaki11, Shinichiro Yoshida12, Mitsutoshi Kurosawa13, Akiko Saito14, Hirokazu Nagai2,14 (1.Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 2.Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 3.Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, 4.Hematology, National Hospital Organization Matsumoto Medical Center, Matsumoto, Japan, 5.Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 6.Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan, 7.Hematology, National Hospital Organization Himeji Medical Center, Himeji, Japan, 8.Hematology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan, 9.Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan, 10.Hematology, National Hospital Organization Nishibeppu Hospital, Beppu, Japan, 11.Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, 12.Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan, 13.Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan, 14.Clinical Rresarch Center, National Hospital Organization Nagoya Medical Center, Japan)

Nobuko Kubota1, Takashi Watanabe2,18, Kensei Tobinai2, Masashi Wakabayashi3, Yasuo Morishima4, Tomohiro Kinoshita5, Kohsuke Asagoe6, Motoko Yamaguchi7, Kiyoshi Ando8, Michinori Ogura9, Masafumi Taniwaki10, Naokuni Uike11, Tadashi Yoshino12, Shigeru Nawano13, Takashi Terauchi14, Tomomitsu Hotta15, Kunihiro Tsukasaki16, Hirokazu Nagai17 (1.Hematol., Saitama Cancer Center, Ina, Saitama, Japan, 2.Hematol., National Cancer Center Hosp., Tokyo, Japan, 3.JCOG Data Center, National Cancer Center, Tokyo, Japan, 4.Hematol. and Cell Therapy, Aichi Cancer Center, Nagoya, Japan, 5.Hematol. and Oncol., Nagoya Univ., Nagoya, Japan, 6.Hematol. and Oncol., Shiga General Hosp., Moriyama, Japan, 7.Hematol. and Oncol., Mie Univ., Tsu, Japan, 8.Hematol. and Oncol., Tokai Univ., Kanagawa, Japan, 9.Hematol. and Oncol., Nagoya Daini Red Cross Hosp., Nagoya, Japan, 10.Hematol. and Oncol., Kyoto Pref. Univ., Kyoto, Japan, 11.Hematol., Kyusyu Cancer Center, Fukuoka, Japan, 12.Pathol., Okayama Univ., Okayama, Japan, 13.Radiol., International Univ. of Health and Welfare, Tokyo, Japan, 14.Nuclear Med., Cancer Institute Hosp., Tokyo, Japan, 15.NHO Nagoya Medical Center, Nagoya, Japan, 16.Hematol., National Cancer Center Hosp. East, Kashiwa, Japan, 17.Hematol., NHO Nagoya Medical Center, Nagoya, Japan, 18.Immuno-Gene Therapy, Mie Univ., Tsu, Japan)

Motoko Yamaguchi1, Ritsuro Suzuki2, Masahiko Oguchi3, Kana Miyazaki1, Senzo Taguchi3, Jun Amaki4, Takeshi Maeda5, Nobuko Kubota6, Dai Maruyama7, Yasuhito Terui3, Nodoka Sekiguchi8, Jun Takizawa9, Hiroyuki Tsukamoto10, Tohru Murayama11, Toshihiko Ando12, Hiroshi Matsuoka13, Masatoshi Hasegawa14, Hideho Wada15, Rika Sakai16, Yoshihiro Kameoka17, Norifumi Tsukamoto18, Ilseung Choi19, Yasufumi Masaki20, Kazuyuki Shimada21, Noriko Fukuhara22, Takahiko Utsumi23, Nobuhiko Uoshima24, Yoshitoyo Kagami25, Naoko Asano26, Naoyuki Katayama1 (1.Mie Univ. Grad. Sch. of Med., Tsu, Japan, 2.Shimane Univ. Hosp., Izumo, Japan, 3.Cancer Institute Hosp. of JFCR, Tokyo, Japan, 4.Tokai Univ., Kanagawa, Japan, 5.Kurashiki Central Hosp., Kurashiki, Japan, 6.Saitama Cancer Ctr., Ina, Japan, 7.National Cancer Ctr. Hosp., Tokyo, Japan, 8.Shinshu Univ., Matsumoto, Japan, 9.Niigata Univ., Niigata, Japan, 10.Showa Univ., Tokyo, Japan, 11.Hyogo Cancer Ctr., Akashi, Japan, 12.Saga Univ., Saga, Japan, 13.Kobe Univ., Kobe, Japan, 14.Nara Med. Univ., Kashihara, Japan, 15.Kawasaki Med. Sch., Kurashiki, Japan, 16.Kanagawa Cancer Ctr., Yokohama, Japan, 17.Akita Univ., Akita, Japan, 18.Gunma Univ. Hosp., Maebashi, Japan, 19.NHO Kyushu Cancer Ctr., Fukuoka, Japan, 20.Kanazawa Med. Univ., Ishikawa, Japan, 21.Nagoya Univ., Nagoya, Japan, 22.Tohoku Univ., Sendai, Japan, 23.Shiga Med. Ctr. for Adults, Moriyama, Japan, 24.Japanese Red Cross Kyoto Daini Hosp., Kyoto, Japan, 25.Toyota Kosei Hosp., Toyota, Japan, 26.Shinshu Med. Ctr., Suzaka, Japan)

Ayumi Fujimoto1, Fumihiro Ishida2,8, Koji Izutsu3, Satoshi Yamasaki4, Dai Chihara5, Junji Suzumiya1, Tetsuo Mitsui6, Kazuteru Ohashi7, Hideyuki Nakazawa8, Hikaru Kobayashi9, Junya Kanda10, Takahiro Fukuda11, Yoshiko Atsuta12, Ritsuro Suzuki1 (1.Oncology and Hematology, Shimane University Hospital, Izumo, Japan, 2.Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan, 3.Hematology, National Cancer Center Hospital, Tokyo, Japan, 4.Hematology and Clinical Research Institute, Kyushu Medical Center, Fukuoka, Japan, 5.Center for Cancer Research National Cancer Institute, Bethesda, MD, USA, 6.Pediatrics, Yamagata University School of Medicine, Yamagata, Japan, 7.Hematology, Komagome Hospital, Tokyo, Japan, 8.Hematology, Shinshu University School of Medicine, Matsumoto, Japan, 9.Hematology, Nagano Red Cross Hospital, Nagano, Japan, 10.Hematology and Oncology, Kyoto University, Kyoto, Japan, 11.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 12.Japanese Data Center for Hematopoietic Cell Transplantation)